Search

everythinglearnresearchcommunity

for

Search:↓

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Finasteride may worsen blood sugar control in diabetic patients.

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Neurohormones help control skin health and could treat skin disorders.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Using neurohormones to control keratin can lead to new skin disease treatments.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Obese and lean women with PCOS have different symptoms and need different treatments.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The control system for hair growth cycles is not well understood and needs more research.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.